NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy makes its own CAR-T cells to battle bone marrow cancer
Disease control Recruiting nowThis early-stage study tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or not responded to treatment. Instead of taking cells out of the body to make them fight cancer, this therapy delivers a gene directly into the body to create canc…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Virus therapy takes on childhood brain cancer in new trial
Disease control Recruiting nowThis early-stage trial tests whether a specially engineered virus, G207, is safe for children with cerebellar brain tumors that have come back or not responded to standard treatments. The virus is injected directly into the tumor, and a low dose of radiation is given to help the …
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a drug already approved for some cancers help people with rare tumors?
Disease control Recruiting nowThis study tests a drug called atezolizumab in people with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). The drug is already approved for certain cancers, and researchers want to see if it works for other cancer types with these ge…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC